Introduction
The excretion of 15 N following the administration of 15 N-amino acid and 15 N-ammonium has been investigated in a number of human metabolic states [2, 8, 11, 12, 16, 19, 21, 23] . When the intake of protein in the diet is normal, the isotope ingested in these studies rapidly and extensively labels urea in urine ( Fig. 1) [2, 8, 11, 12, 21, 23] . For 15 N-amino acid, the general pathway to 15 N-urea involves initial transamination with a-ketoglutaric acid to form glutamic acid [1] . Glutamic acid may then undergo deamination to yield ammonium ion for the synthesis of citrulline via carbamyl phosphate [7] or undergo transamination with oxaloacetic acid to yield aspartic acid which can in turn react with citrulline to form arginino-succinic acid [18] . When 15 N-ammonium is ingested, the sequence of metabolic events is less clear. Ammonium ion can participate in the synthesis of glutamine, glutamic acid, and urea ( Fig. 1) . Studies of the excretion of 15 N in adult subjects have been compatible with substantial direct incorporation of ingested 15 N-ammonium into urea [21, 23] . In premature infants receiving high pro-N in congenital hyperammonemia 253 tern diets, the pattern of excretion of 15 N following the ingestion of 15 N-ammonium chloride suggests little direct incorporation of the nitrogen of ammonium ion into urea [12] . In those infants this nitrogen seems to be incorporated into amino acids and subsequently used, to a large extent, for the synthesis of urea. When nitrogen in the diet is restricted in the premature infant and in other human subjects, the production of 15 N-urea from ingested 15 N-ammonium ion is reduced [12, 19, 23] . Under these circumstances, the nitrogen of ammonium ion is retained as amino acid nitrogen at the expense of urea production.
The relation of the synthesis of urea to protein intake in diet is particularly significant in considering those inborn errors of metabolism which are associated with hyperammonemia. For infants with these disorders, reduction in protein in diet has been associated with symptomatic improvement [3] . The present report deals with the metabolism of compounds labeled with 15 N in an infant with congenital hyperammonemia and reduced activity of hepatic carbamyl phosphate synthetase. She was maintained on a low protein diet, of clinical necessity, throughout these studies. The results are compared with those obtained in similar studies of other infants receiving both high and low protein diets.
Case History
A brief description of this patient, together with some of the data presented here, appeared elsewhere [5] , as has a detailed presentation of the clinical history and general laboratory evaluation [6] .
JS, a Caucasian female infant, was evaluated at 5 weeks of age for episodic vomiting and lethargy leading to coma, precipitated by formula feedings and alleviated by feeding clear protein-free fluids. Family history revealed that a female sibling had expired at 5 months of age with a clinical history identical with that of the patient.
Physical examination was unremarkable. Laboratory evaluation revealed hyperammonemia (400 /ig/100 ml, determined by the Conway method as described by Faulkner and Britton [4] ), modest elevation of glycine in the plasma (5.9 mg/100 ml), and nonprotein nitrogen in the blood within the lower limits of normal (22 mg/100 ml). Glutamine in the plasma ranged from 3.7 to 10.5 mg/100 ml (normal, [6] [7] [8] [9] . During the course of her illness she exhibited intermittent ketoacidosis and neutrapenia. Methylmalonic acid was not present in her urine.
Reduction of protein to 1.0 g/kg/day was associated with marked improvement in her neurologic state and with relatively normal psychomotor development. This amount of protein was, however, insufficient for growth. She developed hypoalbuminemia and osteoporosis, necessitating an increase in protein to 1.3 g protein/kg/day.
When she was 5 months old, exploratory biopsy of the liver was performed under general anesthesia. By contrast radiography the portal venous system was normal. Assays of enzymes of the urea cycle by methods described elsewhere [6, 22] In the immediate postoperative period, she developed severe metabolic ketoacidosis and expired in spite of vigorous supportive efforts. Postmortem examination revealed only fatty metamorphosis of the liver, which was also noted in the biopsy specimen.
Materials and Methods
Urine specimens were analyzed for urea nitrogen and 15 N, and ammonia nitrogen and 15 N by methods described earlier [11] .
Labeled compounds were obtained as follows: Experimental Subjects (Table I) The affected infant is described above. Three control subjects were patients at Babies Hospital: DC and St, normal premature infants, and BS, a normal infant awaiting placement. Two subjects with Down's syndrome (SA and BE) had been in the Richmond Sanatorium since shortly after birth and were in stable clinical condition.
Experimental Method
The infants were given the labeled compounds in conjunction with feedings [27] . Spontaneously voided urine specimens were collected separately, frozen immediately in Dry Ice, and thawed just prior to analysis. For studies of the effects of low protein diets, the infants were given the specified amount of protein with enough additional carbohydrate and fat to make the diet isocaloric with respect to the previous high protein diet (Table I ). The labeled compounds were administered 5-9 days after the low protein diet was instituted.
For studies of the effect of loading doses of citrulline and orthithine-HCl on the metabolism of orally administered 15 NH 4 C1, the infants were given either citrulline or ornithine-HCl (0.3 g/kg/day) in divided doses for 4 consecutive days. The metabolism of orally administered 15 NH 4 C1 was evaluated on the 4th day of amino acid loading (Table I) .
Results
As protein in the diet was restricted, the recovery of 15 N as urea following the ingestion of 15 NH 4 C1 was reduced in all the infants studied ( Table I ). The patient, JS, excreted the smallest percentage of the 15 N administered as urea, but also had the lowest protein intake (Table I ). For both JS and an infant with Down's syndrome (BE), the administration of supplemental ornithine-HCl or citrulline resulted in increased recovery of 15 N-urea after the administration N-glycine fell from initially high values to values near 1 after 5.5 hr in both a premature infant and an infant with Down's syndrome when these infants received a normal diet (Fig. 2) . When protein was restricted, the ratio did not reach unity during the 8-hr study period and was higher for the premature infant than for the infant with Down's syndrome. In the study of JS, the patient, the ratio was even higher than in the case of the premature infant. When fell to values less than 1 at the end of 3 hr in studies of two infants with Down's syndrome receiving both high and low protein diets, a normal infant receiving a low protein diet, and a premature infant receiving a high protein diet (Fig.  3) . In both infants with Down's syndrome, the ratio was greater than 1 for a longer period of time when protein was restricted in the diet than when protein was normal. For the premature infant receiving a low protein diet [ 1B N-NH 3 ]/[ 15 N-urea] remained greater than 1 for 8 hr, and was very similar to that found in the study of the hyperammonemic infant who was also receiving a low protein diet (Fig. 3) .
Substantial incorporation of 15 N from administered 15 NH 4 C1 into the glycine moiety of hippuric acid was noted when sodium benzoate was administered to- gether with the labeled salt to JS. (Table II) . This was also noted in a control study of a premature infant (Table II) . When 15 N-citrulline was administered to the patient, JS, urea was rapidly labeled and ammonia was only slowly labeled (Fig. 4) .
When either ornithine-HCl (Fig. 5) or citrulline ( Fig. 6) 13 N concentration was higher in ammonia and lower in urea in the urine when citrulline was administered than when ornithine-HCl was administered (Table  III) . (Table I) . However, for the control infants, reduction of protein in the diet was accompanied by reduction in the excretion of 15 Nurea. On a low protein diet, the premature infant excreted a percentage of the dose very similar to that excreted by the hyperammonemic infant. Since the diet of the hyperammonemic infant was lower in protein than were the other restricted diets, it seems unlikely that the small amount of 13 N-urea excreted by the hyperammonemic infant can be ascribed specifically to her disease. N-glycine is administered to humans, the labeled nitrogen is distributed among many amino acids in the total pool of amino acids by transamination and other reactions [20] . Ammonia in urine, derived directly from amino acids and amino acid amides [17] is rapidly labeled following the ingestion of 15 Nglycine, and serves, to a limited extent, as a direct indicator of the level of the label present in the total pool of amino acids. Since the urea pool is very large compared with the excretory pool of ammonia nitrogen, the concentration of label rises more slowly in urea than in ammonia. As 15 [26] . In man, the achievement of this precursor-product relation is influenced by complicating factors, particularly the time of equilibration between 15 N-glycine and the total amino acid pool [11, 24] 15 N-glycine in association with normal diets. As shown in Figure 2 That the protein content of the diet can influence the achievement of isotopic equality between ammonia and urea in urine is shown by the studies in which the premature infant and the infant with Down's syndrome received 1B N-glycine after 10 and 7 days, respectively, of lowered protein intake.
In each of these infants, Although the values for JS occupy an extreme position, suggesting an impairment in the incorporation of amino acid nitrogen into urea, it must be noted that the protein content of her diet (1.0 g/kg/day) was lower than that of the controls (1.5 g/kg/day). It is also possible that the hyperammonemic infant, who had elevated levels of glycine in plasma and urine, exhibited some specific abnormality in the metabolism of glycine. A reduction in the conversion of glycine to serine has been demonstrated in the ketotic glycinemia of Nyhan and Childs [15] , a disease which is considered to result from a primary defect in the metabolism of propionic acid and to which the present case shows many similarities. Such an impairment in glycine metabolism could account for a reduction in the availability of glycine nitrogen for urea synthesis.
Incorporation of 15 N from Ingested ^NH^Cl into Glycine
Since JS was able to synthesize 15 N-hippuric acid from 1S NH 4 CL it is clear that metabolic pathways leading from ammonia to glycine were utilized by JS (Table II) . Although quantitative data were not obtained, the finding of similar labeling of hippuric acid by a premature infant fed 15 15 N into both ammonia and urea in urine. In the few appropriate studies available [13, 23, 25] , the concentration of 15 N-NH 3 falls rapidly and becomes less than the [ 15 N-urea] soon after administration of the labeled compound (0.6-3.0 hr), regardless of the level of protein in the diet. By contrast, it is noted in Figure 3 (Fig. 3) . This finding was originally interpreted [5] as evidence of a defect in the direct incorporation of the nitrogen of ingested ammonia into urea, with consequent incorporation of abnormally large amounts of ammonium nitrogen into the pool of amino acids (presumably largely glutamine), giving rise to ammonia in the urine. This interpretation seems reasonable, particularly in view of the finding by Levin and co-workers [10] that glutamine is increased in both plasma and urine in patients with deficient hepatic ornithine transcarbamylase. However, in our patient, JS, glutamine in the plasma was not consistently elevated, nor was there any evidence of consistently elevated glutamine in the urine.
Subsequent studies in other infants (Fig. 3 ) have cast additional doubt on this interpretation. In all these studies except one, equality of 15 N concentration in ammonia and urea in urine was achieved within 5 hr after administration of the isotope. However, for both control infants studied while receiving high and low protein diets, [ The values obtained in the study of the premature infant in association with reduced protein intake are quite similar to those for JS. The interpretation of these findings is complicated by factors which affect the appropriateness of the controls. The infant with congenital hyperammonemia was born at term and was maintained for a long period of time on a diet very low in protein. Although the protein content of the diet was maintained at the highest level tolerated from a neurologic point of view, she exhibited protein malnutrition and failure to thrive. No single infant in the control group is appropriate from all these points of view, and no infant in the control group suffered from potein malnutrition. The studies may indicate that the hyperammonemic infant metabolized 15 NH 4 C1 abnormally with respect to proper controls for age, maturity, and general clinical state, but it is clear from the studies of the premature infant that this mode of metabolism is not unique.
Two points concerning the conceptual basis of these studies deserve comment. The first involves the concept of direct incorporation of the nitrogen of ingested ammonium ion into urea. Studies of the metabolism of ingested 15 NH 4 + in premature infants are compatible with a mode of metabolism in which the nitrogen of ingested ammonium ion is first incorporated into amino acids and then used for the synthesis of urea [12] . The metabolism of 15 N-glycine in these infants indicates that the rate of turnover of the total amino acid pool is quite slow by comparison with that of the adult human [11] . It is therefore possible that the incorporation of ingested ammonium ion first into amino acids and then into urea is the normal sequence of events in human metabolism, made apparent in premature infants by the slow turnover of amino acids and ambiguous in adults by the rapid turnover of amino acids. This possibility raises a serious question about the validity of measuring urea synthesis from ingested ammonium ion as a test of the direct incorporation of ingested ammonium into urea.
The second point involves the failure of 
Metabolism of Ingested 15 NH^Cl in the Presence of a Low Protein Diet Supplemented with OrnithineHCl or Citrulline
In an effort to improve the clinical course of JS, the effects of supplemental ornithine-HCl and citrulline on the metabolism of ingested 13 NH 4 + were examined. The percentage of label excreted as urea was greater when the diet was supplemented with ornithine-HCl than when it was supplemented with citrulline (Table  1) . With either ornithine-HCl or citrulline added to the diet, the hyperammonemic infant excreted only very little 15 N-urea, but the percentage of the dose excreted was considerably greater in each case than that excreted when 15 NH 4 C1 was given without the supplemental amino acid. The total nitrogen intake of JS was greater during the studies of supplementation (1.3 g protein/kg + amino acid supplement/day) than during the original study of 15 NH 4 C1 metabolism (1.0 g protein/kg/day).
For the control infant with Down's syndrome receiving a diet containing 1.5 g protein/kg/day, results were similar in that supplemental ornithine-HCl and citrulline both increased the excretion of (Table III) .
Although the substantial quantitative differences between the excretion of 13 N-urea by the hyperammonemic infant and excretion by the infant with Down's syndrome seem out of proportion to the difference in nitrogen intake by the two infants, the effect on this study of prolonged nitrogen deprivation in the hyperammonemic infant and of individual variation in nitrogen requirement cannot be ascertained. As in the other studies of the metabolism of compounds labeled with 13 N, no unique abnormality attributable to congenital hyperammonemia was detected.
Concluding Remarks
Although some abnormality in the synthesis of This concept is further supported by the observation in mammalian species that the levels of activity of the enzymes of the urea cycle rise and fall coordinately when protein in the diet is raised and lowered [14, 22] . Therefore, a selective reduction in the level of hepatic carbamyl phosphate synthetase would seem, a priori, to be abnormal. However, Kirkman and Kiesel [9] have obtained evidence that the activity of carbamyl phosphate synthetase may be selectively lowered in infants receiving low protein diets. If this is true, an inborn genetic lowering of the activity of this enzyme may be indistinguishable from adaptive change when a low protein diet is ingested.
Summary
The excretion of 15 N in the urine following oral administration of compounds labeled with 15 N was evaluated in an infant having congenital hyperammonemia associated with reduced activity of hepatic carbamyl phosphate synthetase. Although the pattern of excretion of 15 N in the affected infant was different from that in controls appropriate for age, sex, and presence of chronic disease, no unique mode of metabolism, specific for congenital hyperammonemia, could be defined.
Addendum
Since completion of the manuscript, interesting enzymatic evidence has been obtained which bears on our speculation concerning the nature of clinical disease associated with partial and complete enzymatic defects in the elimination of nitrogen. Campbell and coworkers studied a male infant who died on the 5th day of life of intractable hyperammonemia. Liver tissue obtained shortly after death contained no activity of ornithine transcarbamylase. A brother, born earlier, had died similarly. These cases are in marked contrast to females affected by this apparently sex-linked disorder. The latter show mild to severe hyperammonemia over a period of years, and have levels of hepatic ornithine transcarbamylase which are readily detectable but generally less than 10% of normal (cf. [10] ). (Campbell, A. G. M., Rosenberg, L. E., Snodgrass, P. J., and Nuzum, C. T.: Complete ornithine transcarbamylase deficiency: a cause of lethal hyperammonemia (Abstract). Pediat. Res., 5: 394 (1971) .)
